indolepropanol phosphate has been researched along with Carcinoma in 1 studies
indolepropanol phosphate: binds specifically to the alpha subunit, but not to the beta subunit of tryptophan synthase
3-(indol-3-yl)propyl phosphate : An monoalkyl phosphate compound having an O-3-(indol-3-yl)propyl substituent.
Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Varinelli, L | 1 |
| Caccia, D | 1 |
| Volpi, CC | 1 |
| Caccia, C | 1 |
| De Bortoli, M | 1 |
| Taverna, E | 1 |
| Gualeni, AV | 1 |
| Leoni, V | 1 |
| Gloghini, A | 1 |
| Manenti, G | 1 |
| Bongarzone, I | 1 |
1 other study available for indolepropanol phosphate and Carcinoma
| Article | Year |
|---|---|
4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas.
Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma; Carcinoma, Papillary; Cell Cycle; Cell P | 2015 |